Label: BRILLIA HEALTH COUGH CONTROL (lapine bradykinin immune globulin (12c, 30c, 50c), lapine morphine immune globulin (12c, 30c, 50c), lapine histamine immune globulin- 12c, 30c, 50c tablet

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated January 18, 2022

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active Ingredients

    Lapine bradykinin immune globulin 12C, 30C, 50C Purpose Reduces frequency and intensity of cough
    Lapine morphine immune globulin 12C, 30C, 50C Purpose Reduces pain response
    Lapine histamine immune globulin 12C, 30C, 50C Purpose.Reduces histamine and inflammation response

  • Purpose

    Homeopathic,
    Reduces frequency and intensity of cough
    Reduces pain responseLapine histamine immune
    Reduces histamine and inflammation response

  • Uses

    • Suppresses wet and dry cough
    • Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat
    • Antihistamine and decongestant/anti-inflammatory
    • Reduces sore throat pain

  • Warnings

    Stop use and ask a doctor if symptoms persist or worsen.
    If pregnant or breast-feeding, ask a health professional before use.
    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
    Allergic (hypersensitivity) reactions may occur in very rare cases.
    Do not use if known sensitivity to Brillia Health Cough Control or
    any of its ingredients exists.

  • Stop use

    Stop use and ask a doctor if symptoms persist or worsen.

  • Pregnancy

    If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Allergies

    Allergic (hypersensitivity) reactions may occur in very rare cases.

  • Do Not Use

    Do not use if known sensitivity to Brillia Health Cough Control or
    any of its ingredients exists.

  • Directions

    • For adults and children 3 years and older.
    • Take orally by holding tablet in the mouth until completely dissolved, without food.
    • 1 to 2 tablets 3 times daily.
    For severe symptoms, take 4 to 6 times daily for the first 3 days.

  • Other Information

    • Store in original package below 25°C or 77°F.
    • Do not use if blister pack is torn or broken.

  • Inactive ingredients

    Isomalt, Microcrystalline cellulose, Magnesium stearate, Citric acid (anhydrous), Aspartame, Sodium saccharin.

  • PRINCIPAL DISPLAY PANEL

    20 Tablets NDC: 72123-007-01

    LABEL 1

  • INGREDIENTS AND APPEARANCE
    BRILLIA HEALTH COUGH CONTROL 
    lapine bradykinin immune globulin (12c, 30c, 50c), lapine morphine immune globulin (12c, 30c, 50c), lapine histamine immune globulin (12c, 30c, 50c) tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72123-007
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LAPINE MORPHINE IMMUNE GLOBULIN (UNII: OS064NQ92E) (LAPINE MORPHINE IMMUNE GLOBULIN - UNII:OS064NQ92E) LAPINE MORPHINE IMMUNE GLOBULIN12 [hp_C]
    LAPINE BRADYKININ IMMUNE GLOBULIN (UNII: FX59DZ02OS) (LAPINE BRADYKININ IMMUNE GLOBULIN - UNII:FX59DZ02OS) LAPINE BRADYKININ IMMUNE GLOBULIN12 [hp_C]
    LAPINE HISTAMINE IMMUNE GLOBULIN (UNII: 7U4T47R0DD) (LAPINE HISTAMINE IMMUNE GLOBULIN - UNII:7U4T47R0DD) LAPINE HISTAMINE IMMUNE GLOBULIN12 [hp_C]
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    ISOMALT (UNII: S870P55O2W)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    ASPARTAME (UNII: Z0H242BBR1)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    Product Characteristics
    ColorwhiteScorescore with uneven pieces
    ShapeROUNDSize9mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72123-007-012 in 1 BOX07/31/2020
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic07/31/2020
    Labeler - Hadaf LLC (094114708)
    Establishment
    NameAddressID/FEIBusiness Operations
    Santonika Uab520214047manufacture(72123-007)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!